Tian'an Pharmaceutical Co., Ltd. (TNPH)

Tian'an Pharmaceutical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004
Revenue	10.65	7.08	3.52	0.61
Revenue Growth (YoY)	50.53%	101.19%	474.38%	-
Cost of Revenue	3.35	2.48	0.97	0.19
Gross Profit	7.3	4.59	2.55	0.42
Selling, General & Admin	3.49	2.88	0.98	0.13
Operating Expenses	3.49	2.88	1.29	0.34
Operating Income	3.81	1.71	1.25	0.09
Interest Expense	-0.15	-	-	-
Interest & Investment Income	-	0.03	0.02	0.03
Other Non Operating Income (Expenses)	0.04	0.06	0	-
EBT Excluding Unusual Items	3.7	1.8	1.28	0.11
Gain (Loss) on Sale of Assets	-	-0	-	-
Pretax Income	3.7	1.8	1.28	0.11
Income Tax Expense	0.56	0.28	0.22	-
Earnings From Continuing Operations	3.14	1.52	1.06	0.11
Minority Interest in Earnings	-0	0	-0	-
Net Income	3.14	1.52	1.06	0.11
Net Income to Common	3.14	1.52	1.06	0.11
Net Income Growth	106.74%	43.28%	844.10%	-
Shares Outstanding (Basic)	14	14	14	14
Shares Outstanding (Diluted)	14	14	14	14
EPS (Basic)	0.22	0.11	0.08	0.01
EPS (Diluted)	0.22	0.11	0.08	0.01
EPS Growth	106.74%	43.28%	844.17%	-
Free Cash Flow	2.55	1.41	0.69	-2.22
Free Cash Flow Per Share	0.18	0.10	0.05	-0.16
Gross Margin	68.54%	64.90%	72.46%	69.15%
Operating Margin	35.81%	24.16%	35.67%	14.03%
Profit Margin	29.51%	21.49%	30.17%	18.36%
Free Cash Flow Margin	23.98%	19.94%	19.63%	-362.22%
EBITDA	4.31	2.18	1.57	0.29
EBITDA Margin	40.48%	30.86%	44.72%	48.08%
D&A For EBITDA	0.5	0.47	0.32	0.21
EBIT	3.81	1.71	1.25	0.09
EBIT Margin	35.81%	24.16%	35.67%	14.03%
Effective Tax Rate	15.03%	15.55%	17.18%	-
Advertising Expenses	2.1	1.64	0.55	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.